Ikena Oncology, Inc. Contracts & Agreements

34 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Collaboration, Option and License Agreement, dated January 5, 2021, by and between Inmagene Biopharmaceuticals and HUTCHMED Limited (formerly known as Hutchison MediPharma...
Ikena Oncology, Inc.
Pharmaceuticals
2025
Inmagene Biopharmaceuticals 2019 Stock Incentive Plan, and form of stock option notice, and award agreement and restricted stock unit award agreement thereunder
Bonus & Incentive Agreements
Ikena Oncology, Inc.
Pharmaceuticals
2025
Form of Indemnification Agreement between ImageneBio, Inc. and each of its directors and executive officers
Ikena Oncology, Inc.
Pharmaceuticals
2025
Offer Letter, dated December 26, 2022, by and between Inmagene Biopharmaceuticals and Jonathan Wang
Ikena Oncology, Inc.
Pharmaceuticals
2025
Offer Letter, dated December 11, 2022, by and between Inmagene Biopharmaceuticals and Yufang Lu
Ikena Oncology, Inc.
Pharmaceuticals
2025
Offer Letter, dated October 10, 2023, by and between Inmagene Biopharmaceuticals and Erin Butler
Ikena Oncology, Inc.
Pharmaceuticals
2025
Severance Rights Agreement, dated March 6, 2025, by and between Inmagene Biopharmaceuticals and Jonathan Wang
Ikena Oncology, Inc.
Pharmaceuticals
2025
Severance Rights Agreement, dated October 8, 2024, by and between Inmagene Biopharmaceuticals and Yufang Lu
Ikena Oncology, Inc.
Pharmaceuticals
2025
Severance Rights Agreement, dated October 21, 2024, by and between Inmagene Biopharmaceuticals and Erin Butler
Ikena Oncology, Inc.
Pharmaceuticals
2025
Retention Bonus Agreement, dated February 22, 2025, by and between the Registrant and Jotin Marango, M.D., PhD
Bonus & Incentive Agreements
Ikena Oncology, Inc.
Pharmaceuticals
2025
Separation Agreement, dated February 13, 2025, by and between the Registrant and Caroline Germa, M.D
Separation Agreements
Ikena Oncology, Inc.
Pharmaceuticals
2025
Consulting Agreement, dated February 4, 2025, by and between the Registrant and Caroline Germa, M.D
Consulting Agreements
Ikena Oncology, Inc.
Pharmaceuticals
2025
Retention Award Agreement, dated July 1, 2024, by and between the Registrant and Jotin Marango, M.D., Ph.D
Retention Agreements
Ikena Oncology, Inc.
Pharmaceuticals
2024
Retention Award Agreement, dated July 1, 2024, by and between the Registrant and Mark Manfredi, Ph.D
Retention Agreements
Ikena Oncology, Inc.
Pharmaceuticals
2024
Consulting Agreement, dated February 20, 2024, by and between Sergio Santillana and Ikena Oncology, Inc
Consulting Agreements
Ikena Oncology, Inc.
Pharmaceuticals
MA
2024
Agreement and Plan of Merger, dated August 4, 2023, by and among Ikena Oncology, Inc., Portsmouth Merger Sub I, Inc., Portsmouth Merger Sub II, LLC, Pionyr Immunotherapeutics,...
Merger Agreements
Ikena Oncology, Inc.
Pharmaceuticals
DE
2023
Contingent Value Rights Agreement, dated August 4, 2023, by and between Ikena Oncology, Inc. and Computershare Trust Company N.A, as rights agent
Registration Rights Agreements
Ikena Oncology, Inc.
Pharmaceuticals
DE
2023
Underwriting Agreement, dated May 15, 2023, by and between Ikena Oncology, Inc. and Cowen and Company, LLC, as representative of the several underwriters named therein
Underwriting Agreements
Ikena Oncology, Inc.
Pharmaceuticals
NY
2023
Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, as amended
Ikena Oncology, Inc.
Pharmaceuticals
2022
Specimen Common Stock Certificate
Stock Agreements
Ikena Oncology, Inc.
Pharmaceuticals
2021
Form of Underwriting Agreement
Underwriting Agreements
Ikena Oncology, Inc.
Pharmaceuticals
NY
2021
2021 Stock Option and Incentive Plan, and form of award agreements thereunder
Bonus & Incentive Agreements
Ikena Oncology, Inc.
Pharmaceuticals
MA
2021
2021 Employee Stock Purchase Plan
Stock Agreements
Ikena Oncology, Inc.
Pharmaceuticals
MA
2021
Non-Employee Director Compensation Policy
Compensation Agreements
Ikena Oncology, Inc.
Pharmaceuticals
2021
Form of Indemnification Agreement between the Registrant and each of its directors and executive officers
Indemnification Agreements
Ikena Oncology, Inc.
Pharmaceuticals
DE
2021
Form of Amended and Restated Employment Agreement
Employment Agreements
Ikena Oncology, Inc.
Pharmaceuticals
MA
2021
Agreement and Plan of Merger by and among the Registrant, Arrys Merger Sub, Inc., Arrys Therapeutics, Inc. and OrbiMed Private Investments VI, LP, as stockholder representative,...
Merger Agreements
Ikena Oncology, Inc.
Pharmaceuticals
DE
2021
Lease Agreement between the Registrant and OPG MP Parcel Owner (DE) LLC, dated July 31, 2020
Lease Agreements
Ikena Oncology, Inc.
Pharmaceuticals
MA
2021
Patent License Agreement by and between the Registrant and The University of Texas at Austin, on behalf of the Board of Regents of the University of Texas System, dated March 29,...
License Agreements
Ikena Oncology, Inc.
Pharmaceuticals
TX
2021
Master Collaboration Agreement by and between the Registrant and Celgene Corporation (now Bristol-Myers Squibb), dated January 14, 2019
Collaboration Agreements
Ikena Oncology, Inc.
Pharmaceuticals
DE
2021
License Agreement by and between the Registrant and AskAt, Inc., dated December 14, 2017, as amended on December 18, 2018
License Agreements
Ikena Oncology, Inc.
Pharmaceuticals
NY
2021
2016 Stock Incentive Plan, and form of award agreements thereunder
Bonus & Incentive Agreements
Ikena Oncology, Inc.
Pharmaceuticals
DE
2021
Fourth Amended and Restated Investors Rights Agreement
Investor Rights Agreements
Ikena Oncology, Inc.
Pharmaceuticals
DE
2021
Agreement and Plan of Merger by and among the Registrant, AMI Merger Sub, Inc., Amplify Medicines, Inc. and Atlas Venture Fund XI, L.P. as stockholder representative, dated...
Merger Agreements
Ikena Oncology, Inc.
Pharmaceuticals
DE
2021